drugset
Drugs / Gene Modified Neuroblastoma Cells
last change Mar 2006 re-read 3 minutes ago

Gene Modified Neuroblastoma Cells

Cell therapy

Developed for
neuroblastoma
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine

Trials 1

today NCT00062855 · Ph 1
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00062855 Nov 1997 → Aug 2001 neuroblastoma Baylor College of Medicine Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Gene Modified Neuroblastoma Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00062855 ↗
Modality Cell therapy “Gene modified neuroblastoma cells given as 4 subcutaneous injections over 5 weeks” NCT00062855 ↗
Route Subcutaneous “The modified cancer cells will be injected under the patient's skin.” NCT00062855 ↗